Delivery of therapeutic compounds to the brain and other tissues

Details for Australian Patent Application No. 2004253471 (hide)

International Classifications

Event Publications

24 November 2005 PCT application entered the National Phase

PCT publication WO2005/002515 Priority application(s): WO2005/002515

12 January 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 28 Nov 2005

13 July 2006 Assignment before Grant

BioMarin Pharmaceutical Inc. The application has been assigned to Raptor Pharmaceutical Inc.

13 May 2010 Application Accepted

Published as AU-B-2004253471

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.